Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

INBS

Intelligent Bio Solutions (INBS)

Intelligent Bio Solutions Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:INBS
일자시간출처헤드라인심볼기업
2024/05/3006:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
2024/05/2921:30GlobeNewswire Inc.Intelligent Bio Solutions Successfully Completes Recruitment and Begins Subject Screening for FDA 510(k) Pharmacokinetic (PK) StudyNASDAQ:INBSIntelligent Bio Solutions Inc
2024/05/2406:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
2024/05/2321:30GlobeNewswire Inc.Intelligent Bio Solutions Unveils Key Performance Indicator Growth in the United Kingdom as Drug Screening Industry Combats Drug Test Cheating and Searches for Simpler, Faster, Non-Invasive and More Cost-Effective SolutionsNASDAQ:INBSIntelligent Bio Solutions Inc
2024/05/2106:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
2024/05/1721:30GlobeNewswire Inc.Innovative Fingerprint Drug Screening Solution Showcased at the UK's Premier Health and Safety EventNASDAQ:INBSIntelligent Bio Solutions Inc
2024/05/0905:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
2024/05/0821:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INBSIntelligent Bio Solutions Inc
2024/05/0821:30GlobeNewswire Inc.Intelligent Bio Solutions Inc. Reports Fiscal 2024 Third Quarter and Nine-Month Financial Results and Operational HighlightsNASDAQ:INBSIntelligent Bio Solutions Inc
2024/04/1821:30GlobeNewswire Inc.Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue ResultsNASDAQ:INBSIntelligent Bio Solutions Inc
2024/04/1121:30GlobeNewswire Inc.Intelligent Bio Solutions Subsidiary Broadens Intellectual Property Portfolio with Grant of New European Patent with Unitary Effect for Innovative Intelligent Fingerprinting DSR-Plus Cartridge ReaderNASDAQ:INBSIntelligent Bio Solutions Inc
2024/03/2621:30GlobeNewswire Inc.Intelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYCNASDAQ:INBSIntelligent Bio Solutions Inc
2024/03/1308:30GlobeNewswire Inc.Intelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:INBSIntelligent Bio Solutions Inc
2024/03/1121:30GlobeNewswire Inc.Intelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq RulesNASDAQ:INBSIntelligent Bio Solutions Inc
2024/03/0507:26Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:INBSIntelligent Bio Solutions Inc
2024/03/0206:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
2024/03/0107:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
2024/02/2822:30GlobeNewswire Inc.Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) PathwayNASDAQ:INBSIntelligent Bio Solutions Inc
2024/02/2107:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
2024/02/1622:30GlobeNewswire Inc.Intelligent Bio Solutions Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement and Confirms Compliance with Minimum Stockholders’ Equity RequirementNASDAQ:INBSIntelligent Bio Solutions Inc
2024/02/1508:04Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INBSIntelligent Bio Solutions Inc
2024/02/1410:08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INBSIntelligent Bio Solutions Inc
2024/02/1007:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
2024/02/0922:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INBSIntelligent Bio Solutions Inc
2024/02/0922:30GlobeNewswire Inc.Intelligent Bio Solutions Inc. Reports Fiscal Second Quarter and Six-Month Financial Results and Operational HighlightsNASDAQ:INBSIntelligent Bio Solutions Inc
2024/02/0807:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
2024/02/0606:18Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INBSIntelligent Bio Solutions Inc
2024/02/0523:00GlobeNewswire Inc.Intelligent Bio Solutions Inc. Announces Exercise of Previously Issued Warrants for $1.77 Million in Gross ProceedsNASDAQ:INBSIntelligent Bio Solutions Inc
2024/02/0307:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBSIntelligent Bio Solutions Inc
2024/02/0222:30GlobeNewswire Inc.Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Second Quarter and Six-Month Revenue ResultsNASDAQ:INBSIntelligent Bio Solutions Inc
 검색 관련기사 보기:NASDAQ:INBS